Viewing Study NCT06333769


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:31 PM
Study NCT ID: NCT06333769
Status: COMPLETED
Last Update Posted: 2025-08-15
First Post: 2024-03-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module